31 October 2007: Nottingham, UK: Early clinical drug development specialist Pharmaceutical Profiles (Nottingham, UK), uses its proprietary Enterion™ capsule technology to evaluate human drug absorption in order to optimize oral drug bioavailability and develop modified release (MR) formulations for new drugs.
